$PRCT
PROCEPT BioRobotics Corp Stock $prct

$prct Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000162828022021350 Filed on August 05, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$20.35M	$16.69M	$14.20M
YoY Change	134.76%	96.92%	97.4%
Cost Of Revenue	$10.12M	$8.205M	$6.505M
YoY Change	128.5%	67.69%	77.49%
Gross Profit	$10.23M	$8.486M	$7.692M
YoY Change	141.3%	136.84%	118.09%
Gross Profit Margin	50.28%	50.84%	54.18%
Selling, General & Admin	$24.75M	$19.66M	$18.39M
YoY Change	104.27%	59.81%	77.65%
% of Gross Profit	241.95%	231.62%	239.01%
Research & Development	$7.582M	$6.706M	$5.011M
YoY Change	54.14%	49.82%	10.81%
% of Gross Profit	74.11%	79.02%	65.15%
Depreciation & Amortization	$703.0K	$717.0K	$758.0K
YoY Change	-11.68%	-59.38%	-17.16%
% of Gross Profit	6.87%	8.45%	9.85%
Operating Expenses	$32.34M	$26.36M	$23.40M
YoY Change	89.8%	57.14%	57.33%
Operating Profit	-$22.11M	-$17.88M	-$15.70M
YoY Change	72.74%	35.5%	38.43%
Interest Expense	$1.455M	$1.441M	$1.421M
YoY Change	-0.95%	0.35%	-2.94%
% of Operating Profit
Other Income/Expense, Net			-$59.00K
YoY Change			555.56%
Pretax Income	-$22.61M	-$19.18M	-$17.19M
YoY Change	60.34%	-29.99%
Income Tax
% Of Pretax Income
Net Earnings	-$22.61M	-$19.18M	-$17.19M
YoY Change	60.34%	31.58%	34.03%
Net Earnings / Revenue	-111.13%	-114.94%	-121.05%
Basic Earnings Per Share	-$0.51	-$0.43	-$0.39
Diluted Earnings Per Share	-$0.51	-$0.43	-$0.39
COMMON SHARES
Basic Shares Outstanding	44.59M shares	44.32M shares	43.86M shares
Diluted Shares Outstanding	44.64M shares	44.32M shares	43.86M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$249.2M	$269.8M	$284.3M
YoY Change	-22.24%	69.45%
Cash & Equivalents	$249.2M	$269.8M	$284.3M
Short-Term Investments
Other Short-Term Assets	$4.519M	$3.860M	$3.531M
YoY Change	135.12%	175.52%
Inventory	$22.36M	$13.78M	$12.63M
Prepaid Expenses
Receivables	$12.84M	$10.89M	$6.992M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$288.9M	$298.3M	$308.0M
YoY Change	-14.89%	69.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.120M	$4.397M	$4.560M
YoY Change	-10.66%	-58.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$202.0K	$302.0K	$3.814M
YoY Change	-74.0%	-82.01%
Total Long-Term Assets	$35.11M	$12.59M	$12.93M
YoY Change	192.71%	-10.47%
TOTAL ASSETS
Total Short-Term Assets	$288.9M	$298.3M	$308.0M
Total Long-Term Assets	$35.11M	$12.59M	$12.93M
Total Assets	$324.0M	$310.9M	$320.9M
YoY Change	-7.8%	63.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.331M	$3.342M	$2.628M
YoY Change	76.35%	-0.15%
Accrued Expenses	$12.76M	$9.164M	$8.615M
YoY Change	50.22%	10.06%
Deferred Revenue	$2.342M	$1.863M	$1.368M
YoY Change	176.18%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$27.36M	$18.63M	$14.76M
YoY Change	92.95%	35.47%
LONG-TERM LIABILITIES
Long-Term Debt	$50.69M	$50.51M	$50.25M
YoY Change	1.87%	2.05%
Other Long-Term Liabilities	$200.0K	$200.0K	$200.0K
YoY Change	0.0%	-96.06%
Total Long-Term Liabilities	$50.89M	$50.71M	$50.45M
YoY Change	1.86%	-7.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.36M	$18.63M	$14.76M
Total Long-Term Liabilities	$50.89M	$50.71M	$50.45M
Total Liabilities	$103.3M	$71.74M	$68.16M
YoY Change	51.54%	5.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$320.5M	-$297.9M	-$278.7M
YoY Change	31.78%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$220.8M	$239.2M	$252.8M
YoY Change
Total Liabilities & Shareholders Equity	$324.0M	$310.9M	$320.9M
YoY Change	-7.8%	63.15%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$22.61M	-$19.18M	-$17.19M
YoY Change	60.34%	31.58%	34.03%
Depreciation, Depletion And Amortization	$703.0K	$717.0K	$758.0K
YoY Change	-11.68%	-59.38%	-17.16%
Cash From Operating Activities	-$19.85M	-$17.13M	-$18.23M
YoY Change	55.68%	-39.07%	19.96%
INVESTING ACTIVITIES
Capital Expenditures	-$1.514M	-$218.0K	$55.00K
YoY Change	1263.96%	46.31%	41.03%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.514M	-$218.0K	-$55.00K
YoY Change	1263.96%	46.31%	41.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	777.0K	2.862M	$1.291M
YoY Change	-99.55%	-96.72%	5.39%
NET CHANGE
Cash From Operating Activities	-19.85M	-17.13M	-$18.23M
Cash From Investing Activities	-1.514M	-218.0K	-$55.00K
Cash From Financing Activities	777.0K	2.862M	$1.291M
Net Change In Cash	-20.59M	-14.48M	-$17.00M
YoY Change	-112.77%	-124.51%	21.29%
FREE CASH FLOW
Cash From Operating Activities	-$19.85M	-$17.13M	-$18.23M
Capital Expenditures	-$1.514M	-$218.0K	$55.00K
Free Cash Flow	-$18.34M	-$16.91M	-$18.29M
YoY Change	45.07%	-39.52%	20.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001588978
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40797
	dei	Entity Registrant Name EntityRegistrantName	PROCEPT BioRobotics Corporation
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0199180
	dei	Entity Address Address Line1 EntityAddressAddressLine1	900 Island Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Redwood City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94065
	dei	City Area Code CityAreaCode	650
	dei	Local Phone Number LocalPhoneNumber	232-7200
	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value per share
	dei	Trading Symbol TradingSymbol	PRCT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44592286	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	269806000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	304320000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10894000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4464000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	13777000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	13147000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3860000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4242000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	298337000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	326173000	usd
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3814000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	777000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4397000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5045000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2463000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3279000	usd
CY2022Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1614000	usd
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1750000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	302000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	usd
CY2022Q2	us-gaap	Assets Assets	310927000	usd
CY2021Q4	us-gaap	Assets Assets	337024000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3342000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2029000	usd
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6906000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6475000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1863000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1025000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2258000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2105000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4264000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4608000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	18633000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16242000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50507000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50004000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	829000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1991000	usd
CY2022Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1570000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1496000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	200000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	200000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	71739000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	69933000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44538000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44538000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43676000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43676000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	537046000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	528666000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	32000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-54000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-297890000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-261521000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	239188000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	267091000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	310927000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	337024000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16691000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8476000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30888000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15668000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	8205000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	4893000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	14710000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8558000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	8486000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	3583000	usd
	us-gaap	Gross Profit GrossProfit	16178000	usd
	us-gaap	Gross Profit GrossProfit	7110000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6706000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4476000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11717000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8998000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19655000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12299000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38040000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22648000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	26361000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	16775000	usd
	us-gaap	Operating Expenses OperatingExpenses	49757000	usd
	us-gaap	Operating Expenses OperatingExpenses	31646000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-17875000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-13192000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-33579000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24536000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	1441000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	1436000	usd
	us-gaap	Interest Expense InterestExpense	2862000	usd
	us-gaap	Interest Expense InterestExpense	2900000	usd
CY2022Q2	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	132000	usd
CY2021Q2	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	48000	usd
	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	72000	usd
	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	34000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-19184000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14580000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36369000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27402000	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.60
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.82
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.82
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.25
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44324000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44324000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5597000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5597000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44091000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44091000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5216000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5216000	shares
CY2022Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	85000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-9000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	87000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-25000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19099000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14589000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36282000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27427000	usd
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	267091000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1291000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	1552000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17185000	usd
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	252750000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1572000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1289000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	2676000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	85000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-19184000	usd
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	239188000	usd
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402000	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243854000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-182894000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1225000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1225000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	650000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	650000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-16000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-16000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-12822000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-12822000	usd
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402000	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243854000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-193857000	usd
CY2021Q2	prct	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	4448000	shares
CY2021Q2	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	84710000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1415000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	725000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-9000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14580000	usd
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	29850000	shares
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	328564000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-206306000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36369000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27402000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1475000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1765000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4228000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1375000	usd
	prct	Fair Value Adjustment Of Warrants And Gain Loss On Derivative Instruments Net Pretax FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax	74000	usd
	prct	Fair Value Adjustment Of Warrants And Gain Loss On Derivative Instruments Net Pretax FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax	-43000	usd
	prct	Non Cash Lease Accretion Expense NonCashLeaseAccretionExpense	193000	usd
	prct	Non Cash Lease Accretion Expense NonCashLeaseAccretionExpense	158000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6430000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3591000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	684000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2761000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-471000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1412000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	302000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	947000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2120000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	431000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-653000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	503000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	532000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	838000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	431000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-346000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1690000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35357000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28107000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	273000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	149000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-273000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-149000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	84710000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1289000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2864000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2640000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4153000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	87350000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-31477000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	59094000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	305097000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	100907000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	273620000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160001000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	269806000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	159224000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3814000	usd
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	777000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	273620000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160001000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2369000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2369000	usd
	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	53000	usd
	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	-439000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	566000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	226000	usd
	prct	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
	prct	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
	prct	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction	856000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	269800000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-297900000	usd
	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the condensed consolidated financial statements. Management uses significant judgment when making estimates related to its common stock valuation in periods before the Company’s IPO and related stock-based compensation expense, right-of-use lease asset, lease liability, and loan facility derivative liability, as well as certain accrued liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	25.00
CY2021Q3	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	13200000	usd
CY2021Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2900000	usd
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	5329000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6740000	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1025000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	905000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7423000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5502000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	13777000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	13147000	usd
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.60
CY2019Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2500000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	900000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	800000	usd
CY2021Q4	prct	Finite Lived Intangible Asset Expected Annual Amortization Expense FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense	300000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2021	prct	Line Of Credit Facility Gain Loss On Amendment Of Debt Terms LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms	0	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5216000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5216000	shares
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2676000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	725000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4228000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1375000	usd
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-19184000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14580000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36369000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27402000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44324000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44324000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5597000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5597000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44091000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44091000	shares
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.82
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.82
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.25
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6286000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	36543000	shares
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16691000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8476000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30888000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15668000	usd
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1400000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1300000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3330000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	50000000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1238000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2022Q2	prct	Operating Lease Liability And Long Term Debt Maturity Remainder Of Fiscal Year OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear	1238000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2092000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	12500000	usd
CY2022Q2	prct	Operating Lease Liability And Long Term Debt Maturity Year One OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne	14592000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	0	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	37500000	usd
CY2022Q2	prct	Operating Lease Liability And Long Term Debt Maturity Year Two OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo	37500000	usd
CY2022Q2	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	53330000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	243000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	507000	usd
CY2022Q2	prct	Operating Lease Liability And Long Term Debt Maturity Unamortized Debt Discount OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount	-264000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3087000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	50507000	usd
CY2022Q2	prct	Operating Lease Liability And Long Term Debt OperatingLeaseLiabilityAndLongTermDebt	53594000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2258000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2022Q2	prct	Operating Lease Liability And Long Term Debt Current OperatingLeaseLiabilityAndLongTermDebtCurrent	2258000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	829000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50507000	usd
CY2022Q2	prct	Operating Lease Liability And Long Term Debt Excluding Current Maturities OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities	51336000	usd

Files In Submission

Name	View Source	Status
0001628280-22-021350-index-headers.html	Edgar Link	pending
0001628280-22-021350-index.html	Edgar Link	pending
0001628280-22-021350.txt	Edgar Link	pending
0001628280-22-021350-xbrl.zip	Edgar Link	pending
ex311soxcertificationrzadn.htm	Edgar Link	pending
ex312soxcertificationkwate.htm	Edgar Link	pending
ex321soxcertificationrzadn.htm	Edgar Link	pending
ex322soxcertificationkwate.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prct-20220630.htm	Edgar Link	pending
prct-20220630.xsd	Edgar Link	pending
prct-20220630_cal.xml	Edgar Link	unprocessable
prct-20220630_def.xml	Edgar Link	unprocessable
prct-20220630_htm.xml	Edgar Link	completed
prct-20220630_lab.xml	Edgar Link	unprocessable
prct-20220630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRCT
PROCEPT BioRobotics Corp Stock $prct

2022 Q3 Form 10-Q Financial Statement

#000162828022021350 Filed on August 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT PROCEPT BioRobotics Corp Stock $prct

2022 Q3 Form 10-Q Financial Statement

#000162828022021350 Filed on August 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT
PROCEPT BioRobotics Corp Stock $prct